218 related articles for article (PubMed ID: 10930901)
1. Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease.
Hurenkamp GJ; Van Der Ende A; Grundmeijer HG; Tytgat GN; Van Der Hulst RW
Aliment Pharmacol Ther; 2000 Aug; 14(8):1065-70. PubMed ID: 10930901
[TBL] [Abstract][Full Text] [Related]
2. Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group.
Fock KM; Chelvam P; Lim SG
Aliment Pharmacol Ther; 2000 Feb; 14(2):225-31. PubMed ID: 10651664
[TBL] [Abstract][Full Text] [Related]
3. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection?
Goh KL; Parasakthi N; Chuah SY; Cheah PL; Lo YL; Chin SC
Aliment Pharmacol Ther; 1997 Dec; 11(6):1115-8. PubMed ID: 9663838
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study.
Katelaris PH; Adamthwaite D; Midolo P; Yeomans ND; Davidson G; Lambert J
Aliment Pharmacol Ther; 2000 Jun; 14(6):751-8. PubMed ID: 10848659
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains.
Houben MH; Hensen EF; Rauws EA; Hulst RW; Hoff BW; Ende AV; Kate FJ; Tytgat GN
Aliment Pharmacol Ther; 1999 Jul; 13(7):883-9. PubMed ID: 10383522
[TBL] [Abstract][Full Text] [Related]
7. Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
Gschwantler M; Dragosics B; Schütze K; Wurzer H; Hirschl AM; Pasching E; Wimmer M; Klimpfinger M; Oberhuber G; Brandstätter G; Hentschel E; Weiss W
Aliment Pharmacol Ther; 1999 Aug; 13(8):1063-9. PubMed ID: 10468682
[TBL] [Abstract][Full Text] [Related]
8. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy.
Zanten SJ; Bradette M; Farley A; Leddin D; Lind T; Unge P; Bayerdörffer E; Spiller RC; O'Morain C; Sipponen P; Wrangstadh M; Zeijlon L; Sinclair P
Aliment Pharmacol Ther; 1999 Mar; 13(3):289-95. PubMed ID: 10102960
[TBL] [Abstract][Full Text] [Related]
9. One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection.
Veldhuyzen Van Zanten S; Machado S; Lee J
Aliment Pharmacol Ther; 2003 Jun; 17(11):1381-7. PubMed ID: 12786632
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
[TBL] [Abstract][Full Text] [Related]
11. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.
Lind T; Mégraud F; Unge P; Bayerdörffer E; O'morain C; Spiller R; Veldhuyzen Van Zanten S; Bardhan KD; Hellblom M; Wrangstadh M; Zeijlon L; Cederberg C
Gastroenterology; 1999 Feb; 116(2):248-53. PubMed ID: 9922303
[TBL] [Abstract][Full Text] [Related]
12. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies.
Realdi G; Dore MP; Piana A; Atzei A; Carta M; Cugia L; Manca A; Are BM; Massarelli G; Mura I; Maida A; Graham DY
Helicobacter; 1999 Jun; 4(2):106-12. PubMed ID: 10382124
[TBL] [Abstract][Full Text] [Related]
14. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
Moshkowitz M; Konikoff FM; Peled Y; Brill S; Hallak A; Tiomny E; Santo M; Bujanover Y; Gilat T
Aliment Pharmacol Ther; 1996 Dec; 10(6):1015-9. PubMed ID: 8971304
[TBL] [Abstract][Full Text] [Related]
15. High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.
Peitz U; Sulliga M; Wolle K; Leodolter A; Von Arnim U; Kahl S; Stolte M; Börsch G; Labenz J; Malfertheiner P
Aliment Pharmacol Ther; 2002 Feb; 16(2):315-24. PubMed ID: 11860415
[TBL] [Abstract][Full Text] [Related]
16. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.
Lind T; Veldhuyzen van Zanten S; Unge P; Spiller R; Bayerdörffer E; O'Morain C; Bardhan KD; Bradette M; Chiba N; Wrangstadh M; Cederberg C; Idström JP
Helicobacter; 1996 Sep; 1(3):138-44. PubMed ID: 9398894
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study.
Bazzoli F; Zagari M; Pozzato P; Varoli O; Fossi S; Ricciardiello L; Alampi G; Nicolini G; Sottili S; Simoni P; Roda A; Roda E
Aliment Pharmacol Ther; 1998 May; 12(5):439-45. PubMed ID: 9663723
[TBL] [Abstract][Full Text] [Related]
18. The OAC and OMC options.
Unge P
Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S9-17; discussion S23-4. PubMed ID: 10503817
[TBL] [Abstract][Full Text] [Related]
19. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
[TBL] [Abstract][Full Text] [Related]
20. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK
Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
